Component
Rat FSL immobility and sucrose-preference readouts
Rat FSL immobility and sucrose-preference readouts
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
ALCAR reduced immobility and increased sucrose preference in the reported FSL rat model.
Experimental context and source evidence
- evidence_access
- Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
- experimental_contrast
- {"intervention": "ALCAR treatment", "comparator": "Saline-treated FSL rats", "endpoint": "ALCAR reduced immobility and increased sucrose preference in the reported FSL rat model.", "effect_direction": "mixed", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- 100 mg/kg intraperitoneal; early response at 3 days, followed through treatment and withdrawal.
- interpretation_status
- Source-derived curation with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Acetyl-L-carnitine collection; exact intervention and molecular form govern interpretation. · Acetyl-L-carnitine
- plain_language
- ALCAR reduced immobility and increased sucrose preference in the reported FSL rat model.
- primary_references
- L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. | https://pubmed.ncbi.nlm.nih.gov/23382250/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC3607061/ | https://doi.org/10.1073/pnas.1216100110
- source_locator
- Reviewed reference fsl-behavior; Reported persistence after withdrawal is a rodent behavioral observation, not a demonstrated three-day human antidepressant response.
Acetyl-L-carnitine: detailed mechanisms of action (reviewed 6 October 2026) · lines 240–246
AI-assisted original review of primary studies and clearly identified official records. Exact primary access is stated; no independent replication is claimed. · supports · 100 mg/kg intraperitoneal; early response at 3 days, followed through treatment and withdrawal. · Recorded from source · Recorded from source
### fsl-behavior ALCAR reduced immobility and increased sucrose preference in the reported FSL rat model. Reported persistence after withdrawal is a rodent behavioral observation, not a demonstrated three-day human antidepressant response. Model and exposure: 100 mg/kg intraperitoneal; early response at 3 days, followed through treatment and withdrawal. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. | 2013 | https://pubmed.ncbi.nlm.nih.gov/23382250/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC3607061/ | https://doi.org/10.1073/pnas.1216100110 | Access: Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.